Cliff Asness's COGT Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 121,800 shares of Cogent Biosciences, Inc. (COGT) worth $4.33 M, representing 0.00% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in COGT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 133,174 shares. Largest reduction occurred in Q2 2025, reducing 115,686 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Cogent Biosciences (COGT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cogent Biosciences (COGT) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +4,959 | Add 4.24% | 121,800 | $35.52 |
| Q3 2025 | +71,760 | Add 159.18% | 116,841 | $14.36 |
| Q2 2025 | -115,686 | Reduce 71.96% | 45,081 | $7.18 |
| Q1 2025 | +133,174 | Add 482.64% | 160,767 | $5.99 |
| Q4 2024 | +15,881 | Add 135.60% | 27,593 | $7.80 |
| Q3 2024 | +11,712 | New Buy | 11,712 | $10.80 |
| Q3 2023 | -13,633 | Sold Out | 0 | $0.00 |
| Q2 2023 | -2,688 | Reduce 16.47% | 13,633 | $11.84 |
| Q1 2023 | -7,228 | Reduce 30.69% | 16,321 | $10.79 |
| Q4 2022 | +23,549 | New Buy | 23,549 | $11.56 |
Cliff Asness's Cogent Biosciences Investment FAQs
Cliff Asness first purchased Cogent Biosciences, Inc. (COGT) in Q4 2022, acquiring 23,549 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Cogent Biosciences, Inc. (COGT) for 10 quarters since Q4 2022.
Cliff Asness's largest addition to Cogent Biosciences, Inc. (COGT) was in Q1 2025, adding 160,767 shares worth $962,994.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 121,800 shares of Cogent Biosciences, Inc. (COGT), valued at approximately $4.33 M.
As of the Q4 2025 filing, Cogent Biosciences, Inc. (COGT) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Cogent Biosciences, Inc. (COGT) was 160,767 shares, as reported at the end of Q1 2025.